UK Markets closed
  • FTSE 100

    6,351.45
    +17.10 (+0.27%)
     
  • FTSE 250

    19,506.96
    -0.49 (-0.00%)
     
  • AIM

    1,031.03
    +11.60 (+1.14%)
     
  • GBP/EUR

    1.1202
    +0.0041 (+0.37%)
     
  • GBP/USD

    1.3291
    +0.0038 (+0.2858%)
     
  • BTC-GBP

    13,803.19
    -68.99 (-0.50%)
     
  • CMC Crypto 200

    362.95
    +1.52 (+0.42%)
     
  • S&P 500

    3,559.74
    +2.20 (+0.06%)
     
  • DOW

    29,418.24
    +154.76 (+0.53%)
     
  • CRUDE OIL

    42.17
    +0.43 (+1.03%)
     
  • GOLD FUTURES

    1,869.60
    +8.10 (+0.44%)
     
  • NIKKEI 225

    25,527.37
    -106.93 (-0.42%)
     
  • HANG SENG

    26,451.54
    +94.54 (+0.36%)
     
  • DAX

    13,137.25
    +51.09 (+0.39%)
     
  • CAC 40

    5,495.89
    +21.23 (+0.39%)
     

4 Reasons AstraZeneca Gave Daiichi Sankyo Another $1 Billion Upfront

Cory Renauer, The Motley Fool
·4-min read
4 Reasons AstraZeneca Gave Daiichi Sankyo Another $1 Billion Upfront
4 Reasons AstraZeneca Gave Daiichi Sankyo Another $1 Billion Upfront

Here's why AstraZeneca agreed to pay Daiichi Sankyo another enormous sum to develop and commercialize an experimental cancer drug.